Multidrug efflux in gram-negative bacteria: Rationally modifying compounds to avoid efflux pumps
D Gurvic, U Zachariae - bioRxiv, 2023 - biorxiv.org
Gram-negative bacteria cause the majority of critically drug-resistant infections,
necessitating the rapid development of new drugs with Gram-negative activity. However …
necessitating the rapid development of new drugs with Gram-negative activity. However …
A cell-based infection assay identifies efflux pump modulators that reduce bacterial intracellular load
Bacterial efflux pumps transport small molecules from the cytoplasm or periplasm outside
the cell. Efflux pump activity is typically increased in multi-drug resistant (MDR) pathogens; …
the cell. Efflux pump activity is typically increased in multi-drug resistant (MDR) pathogens; …
Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniae
A Vieira Da Cruz, JC Jiménez-Castellanos… - EMBO Molecular …, 2024 - embopress.org
Antimicrobial resistance is a global problem, rendering conventional treatments less
effective and requiring innovative strategies to combat this growing threat. The tripartite …
effective and requiring innovative strategies to combat this growing threat. The tripartite …
Efflux-mediated drug resistance in bacteria: an update
XZ Li, H Nikaido - Drugs, 2009 - Springer
Drug efflux pumps play a key role in drug resistance and also serve other functions in
bacteria. There has been a growing list of multidrug and drug-specific efflux pumps …
bacteria. There has been a growing list of multidrug and drug-specific efflux pumps …
Inhibition of multidrug efflux pumps belonging to the major facilitator superfamily in bacterial pathogens
Bacterial pathogens resistant to multiple structurally distinct antimicrobial agents are
causative agents of infectious disease, and they thus constitute a serious concern for public …
causative agents of infectious disease, and they thus constitute a serious concern for public …
Multidrug efflux pumps and the two-faced janus of substrates and inhibitors
Conspectus Antibiotics are miracle drugs that can cure infectious bacterial diseases.
However, their utility is challenged by antibiotic-resistant bacteria emerging in clinics and …
However, their utility is challenged by antibiotic-resistant bacteria emerging in clinics and …
Efflux in Gram-negative bacteria: what are the latest opportunities for drug discovery?
Introduction The resistance-nodulation-division (RND) family is the most important group of
multidrug efflux pumps in Gram-negative bacteria. Their inhibition increases the …
multidrug efflux pumps in Gram-negative bacteria. Their inhibition increases the …
Quinoline derivatives as promising inhibitors of antibiotic efflux pump in multidrug resistant Enterobacter aerogenes isolates
A Mahamoud, J Chevalier, A Davin-Regli… - Current drug …, 2006 - ingentaconnect.com
Efflux pumps protect the bacterial cell by expelling toxic compounds before they reach
intracellular targets. Because this mechanism actively contributes to the resistance of a …
intracellular targets. Because this mechanism actively contributes to the resistance of a …
Advances in the Discovery of Efflux Pump Inhibitors as Novel Potentiators to Control Antimicrobial-Resistant Pathogens
The excessive use of antibiotics has led to the emergence of multidrug-resistant (MDR)
pathogens in clinical settings and food-producing animals, posing significant challenges to …
pathogens in clinical settings and food-producing animals, posing significant challenges to …
Enhancement of Antibiotic Activity against Multidrug-Resistant Bacteria by the Efflux Pump Inhibitor 3,4-Dibromopyrrole-2,5-dione Isolated from a Pseudoalteromonas …
KE Whalen, KL Poulson-Ellestad… - Journal of natural …, 2015 - ACS Publications
Members of the resistance nodulation cell division (RND) of efflux pumps play essential
roles in multidrug resistance (MDR) in Gram-negative bacteria. Here, we describe the …
roles in multidrug resistance (MDR) in Gram-negative bacteria. Here, we describe the …